Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Timothy Motley

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Plos Genetics|January 19, 2019
The complex architecture and epigenomic impact of plant T-DNA insertionsFlorian Jupe, Angeline C Rivkin, Todd P Michael, et al.
Bioorganic & Medicinal Chemistry Letters|October 17, 2008
2-Aryloxymethylmorpholine histamine H(3) antagonistsMichael A Letavic, John M Keith, Kiev S Ly, et al.
Clinical Chemistry|October 31, 2021
Measurement Biases Distort Cell-Free DNA Fragmentation Profiles and Define the Sensitivity of Metagenomic Cell-Free DNA Sequencing AssaysAdrienne Chang, Omary Mzava, Joan S Lenz, et al.
Psychopharmacology|November 19, 2010
JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in ratsRuggero Galici, Amir H Rezvani, Leah Aluisio, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2007
Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: synthesis and preliminary SAR analysisLaurent Gomez, Michael D Hack, Jiejun Wu, et al.
Molecular Therapy. Nucleic Acids|March 13, 2020
An Antisense Oligonucleotide Leads to Suppressed Transcription of Hdac2 and Long-Term Memory EnhancementShane G Poplawski, Krassimira A Garbett, Rebekah L McMahan, et al.
Psychopharmacology|December 3, 2009
In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptorJames R Shoblock, Natalie Welty, Diane Nepomuceno, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2007
Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strainsJohn J M Wiener, Laurent Gomez, Hariharan Venkatesan, et al.
Cell Reports|August 30, 2016
Tcf4 Regulates Synaptic Plasticity, DNA Methylation, and Memory FunctionAndrew J Kennedy, Elizabeth J Rahn, Brynna S Paulukaitis, et al.
Bioorganic & Medicinal Chemistry Letters|June 22, 2010
Pre-clinical characterization of aryloxypyridine amides as histamine H3 receptor antagonists: identification of candidates for clinical developmentMichael A Letavic, Leah Aluisio, John R Atack, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Plos Genetics|January 19, 2019
The complex architecture and epigenomic impact of plant T-DNA insertionsFlorian Jupe, Angeline C Rivkin, Todd P Michael, et al.
Bioorganic & Medicinal Chemistry Letters|October 17, 2008
2-Aryloxymethylmorpholine histamine H(3) antagonistsMichael A Letavic, John M Keith, Kiev S Ly, et al.
Clinical Chemistry|October 31, 2021
Measurement Biases Distort Cell-Free DNA Fragmentation Profiles and Define the Sensitivity of Metagenomic Cell-Free DNA Sequencing AssaysAdrienne Chang, Omary Mzava, Joan S Lenz, et al.
Psychopharmacology|November 19, 2010
JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in ratsRuggero Galici, Amir H Rezvani, Leah Aluisio, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2007
Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: synthesis and preliminary SAR analysisLaurent Gomez, Michael D Hack, Jiejun Wu, et al.
Molecular Therapy. Nucleic Acids|March 13, 2020
An Antisense Oligonucleotide Leads to Suppressed Transcription of Hdac2 and Long-Term Memory EnhancementShane G Poplawski, Krassimira A Garbett, Rebekah L McMahan, et al.
Psychopharmacology|December 3, 2009
In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptorJames R Shoblock, Natalie Welty, Diane Nepomuceno, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2007
Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strainsJohn J M Wiener, Laurent Gomez, Hariharan Venkatesan, et al.
Cell Reports|August 30, 2016
Tcf4 Regulates Synaptic Plasticity, DNA Methylation, and Memory FunctionAndrew J Kennedy, Elizabeth J Rahn, Brynna S Paulukaitis, et al.
Bioorganic & Medicinal Chemistry Letters|June 22, 2010
Pre-clinical characterization of aryloxypyridine amides as histamine H3 receptor antagonists: identification of candidates for clinical developmentMichael A Letavic, Leah Aluisio, John R Atack, et al.
Pageof 2